3rd Quarter - Report

BROWN RUDNICK LLP for PRIME THERAPEUTICS

Firm
Client
Income
$30,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Issues relating to specialty pharmacy. Implementation of the Biologics Price Competition and Innovation Act (BPCIA) relating to biosimilar naming.

LobbyistCovered position, as disclosed
LISA LAYMAN —
HENRY W MENN —

Contacted: SENATE; Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES

Pharmacy PHA

Issues relating to prescription drug abuse and diversion; HR 4577 - Ensuring Seniors Access to Local Pharmacies Act of 2014

LobbyistCovered position, as disclosed
LISA LAYMAN —
HENRY W MENN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS)

Bills named: H.R. 4577 (113th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.